Cartesian Therapeutics, Inc. (RNAC)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $162k
- Jan 6 · No plan
- Form 4 sales
- 62
- On record
- Form 144 notices
- 17
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeNov 19, 2025 2025
Filed to sell 26,935 shares ($193k)
Jewell Christopher M, Former Affiliate
No 10b5-1 planFiling
- 2 Form 4 saleNo planJan 6, 2026 +48 days
Sold 10,591 shares at $6.82 ($72k)
Davis Blaine, Chief Financial Officer
No 10b5-1 planSold 8% of holdings ($899k position)121,220 shares leftFiling
- 3 Form 4 saleNo planJan 6, 2026 same day
Sold 3,573 shares at $6.82 ($24k)
Miljkovic Milos, Chief Medical Officer
No 10b5-1 planSold 5.7% of holdings ($426k position)58,820 shares leftFiling
- 4 Form 4 saleNo planJan 6, 2026 same day
Sold 23,766 shares at $6.82 ($162k)
Brunn Carsten, President and CEO
No 10b5-1 planSold 6.8% of holdings ($2.4M position)323,530 shares leftFiling
- 5 Form 144 noticeNoticeJan 9, 2026 +3 days
Filed to sell 1,510 shares ($12k)
Jewell Christopher M, Former Affiliate
No 10b5-1 planFiling
- 6 Form 144 noticeNoticeJan 13, 2026 +4 days
Filed to sell 9,000 shares ($69k)
Jewell Christopher M, Former Affiliate
No 10b5-1 planFiling
- 7 Form 144 noticeNoticeJun 2, 2026 +140 days
Filed to sell 3,924 shares ($25k)
Miljkovic Milos, Former Affiliate
No 10b5-1 plan1.1x usual sizeFiling
- 8 Form 144 noticeNoticeJun 9, 2026 +7 days
Filed to sell 35,038 shares ($233k)
Miljkovic Milos, Former Affiliate
No 10b5-1 plan9.8x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (79)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2026 | Jun 9, 2026 | Miljkovic Milos | RNAC | Former Affiliate | Form 144 notice | 35,038 | $233k | Notice | SEC | |
| Jun 2, 2026 | Jun 2, 2026 | Miljkovic Milos | RNAC | Former Affiliate | Form 144 notice | 3,924 | $25k | Notice | SEC | |
| Jan 13, 2026 | Jan 13, 2026 | Jewell Christopher M | RNAC | Former Affiliate | Form 144 notice | 9,000 | $69k | Notice | SEC | |
| Jan 9, 2026 | Jan 9, 2026 | Jewell Christopher M | RNAC | Former Affiliate | Form 144 notice | 1,510 | $12k | Notice | SEC | |
| Jan 6, 2026 | Jan 8, 2026 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 23,766 | $162k | 6.8% | No plan | SEC |
| Jan 6, 2026 | Jan 8, 2026 | Miljkovic Milos | RNAC | Chief Medical Officer | Form 4 sale | 3,573 | $24k | 5.7% | No plan | SEC |
| Jan 6, 2026 | Jan 8, 2026 | Davis Blaine | RNAC | Chief Financial Officer | Form 4 sale | 10,591 | $72k | 8.0% | No plan | SEC |
| Nov 19, 2025 | Nov 19, 2025 | Jewell Christopher M | RNAC | Former Affiliate | Form 144 notice | 26,935 | $193k | Notice | SEC | |
| Jan 6, 2025 | Jan 7, 2025 | Kurtoglu Metin | RNAC | Chief Technology Officer | Form 4 sale | 4,875 | $82k | 7.3% | No plan | SEC |
| Jan 6, 2025 | Jan 7, 2025 | Miljkovic Milos | RNAC | Chief Medical Officer | Form 4 sale | 1,880 | $32k | 5.0% | No plan | SEC |
| Jan 6, 2025 | Jan 7, 2025 | Jewell Christopher M | RNAC | Chief Scientific Officer | Form 4 sale | 2,550 | $43k | 4.6% | No plan | SEC |
| Jan 6, 2025 | Jan 7, 2025 | English Emily | RNAC | Chief Operations Officer | Form 4 sale | 1,797 | $30k | 4.3% | No plan | SEC |
| Jan 6, 2025 | Jan 7, 2025 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 17,271 | $290k | 7.8% | No plan | SEC |
| Jan 6, 2025 | Jan 7, 2025 | Davis Blaine | RNAC | Chief Financial Officer | Form 4 sale | 7,989 | $134k | 7.8% | No plan | SEC |
| Dec 10, 2024 | Dec 11, 2024 | Kurtoglu Metin | RNAC | Chief Technology Officer | Form 4 sale | 13,664 | $345k | 21.1% | No plan | SEC |
| Dec 10, 2024 | Dec 10, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 2,901 | $71k | Notice | SEC | |
| Dec 9, 2024 | Dec 9, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 10,763 | $274k | Notice | SEC | |
| Nov 21, 2024 | Nov 21, 2024 | Kurtoglu Metin | RNAC | Chief Technology Officer | Form 4 sale | 38,689 | $649k | 43.1% | Unusual | SEC |
| Nov 21, 2024 | Nov 21, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 32,789 | $547k | Notice | SEC | |
| Nov 20, 2024 | Nov 20, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 5,700 | $99k | Notice | SEC | |
| Nov 19, 2024 | Nov 19, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 200 | $4k | Notice | SEC | |
| Nov 18, 2024 | Nov 18, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 34,400 | $633k | Notice | SEC | |
| Nov 18, 2024 | Nov 18, 2024 | Kurtoglu Metin | RNAC | Chief Technology Officer | Form 4 sale | 82,368 | $1.4M | 61.7% | Unusual | SEC |
| Nov 15, 2024 | Nov 18, 2024 | Miljkovic Milos | RNAC | Chief Medical Officer | Form 4 sale | 55,000 | $907k | 75.1% | Unusual | SEC |
| Nov 15, 2024 | Nov 18, 2024 | Jewell Christopher M | RNAC | Chief Scientific Officer | Form 4 sale | 52,115 | $875k | 66.8% | Unusual | SEC |
| Nov 15, 2024 | Nov 15, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 22,068 | $379k | Notice | SEC | |
| Nov 15, 2024 | Nov 15, 2024 | Jewell Christopher M | RNAC | Officer | Form 144 notice | 16,065 | $274k | Notice | SEC | |
| Nov 15, 2024 | Nov 15, 2024 | Miljkovic Milos | RNAC | Officer | Form 144 notice | 20,000 | $343k | Notice | SEC | |
| Nov 14, 2024 | Nov 14, 2024 | Kurtoglu Metin | RNAC | Officer | Form 144 notice | 25,900 | $426k | Notice | SEC | |
| Nov 14, 2024 | Nov 14, 2024 | Jewell Christopher M | RNAC | Officer | Form 144 notice | 36,050 | $601k | Notice | SEC | |
| Nov 14, 2024 | Nov 14, 2024 | Miljkovic Milos | RNAC | Officer | Form 144 notice | 35,000 | $565k | Notice | SEC | |
| Sep 25, 2023 | Sep 26, 2023 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 2,932 | $3k | 0.4% | No plan | SEC |
| Sep 25, 2023 | Sep 26, 2023 | Traber Peter G | RNAC | Chief Medical Officer | Form 4 sale | 705 | $747 | 0.2% | No plan | SEC |
| Jan 5, 2023 | Jan 6, 2023 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 41,070 | $46k | 5.0% | Unusual | SEC |
| Jan 5, 2023 | Jan 6, 2023 | Johnston Lloyd P. | RNAC | Chief Operations Officer | Form 4 sale | 9,784 | $11k | 3.6% | Plan not stated | SEC |
| Jan 5, 2023 | Jan 6, 2023 | Kishimoto Takashi Kei | RNAC | Chief Scientific Officer | Form 4 sale | 9,784 | $11k | 2.6% | Plan not stated | SEC |
| Jan 5, 2023 | Jan 6, 2023 | Traber Peter G | RNAC | Chief Medical Officer | Form 4 sale | 11,644 | $13k | 2.5% | Unusual | SEC |
| Dec 5, 2022 | Dec 7, 2022 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 4,522 | $6k | 0.8% | Plan not stated | SEC |
| Sep 28, 2022 | Sep 30, 2022 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 2,692 | $4k | 0.5% | Plan not stated | SEC |
| Sep 2, 2022 | Sep 6, 2022 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 4,768 | $9k | 0.9% | Plan not stated | SEC |
| Mar 2, 2022 | Mar 3, 2022 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 5,443 | $10k | 1.0% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | Traber Peter G | RNAC | Chief Medical Officer | Form 4 sale | 3,226 | $10k | 1.3% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | Kishimoto Takashi Kei | RNAC | Chief Scientific Officer | Form 4 sale | 3,416 | $11k | 1.3% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | Johnston Lloyd P. | RNAC | Chief Operations Officer | Form 4 sale | 3,416 | $11k | 1.9% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 13,597 | $42k | 2.6% | Plan not stated | SEC |
| Dec 10, 2021 | Dec 14, 2021 | Traber Peter G | RNAC | Chief Medical Officer | Form 4 sale | 4,083 | $12k | 2.4% | Plan not stated | SEC |
| Dec 10, 2021 | Dec 14, 2021 | Kishimoto Takashi Kei | RNAC | Chief Scientific Officer | Form 4 sale | 4,370 | $13k | 2.1% | Plan not stated | SEC |
| Dec 10, 2021 | Dec 14, 2021 | Johnston Lloyd P. | RNAC | Chief Operations Officer | Form 4 sale | 4,370 | $13k | 3.9% | Plan not stated | SEC |
| Dec 10, 2021 | Dec 14, 2021 | Name not stated | RNAC | President and CEO | Form 4 sale | 17,196 | $51k | 5.3% | Unusual | SEC |
| Dec 2, 2021 | Dec 3, 2021 | Brunn Carsten | RNAC | President and CEO | Form 4 sale | 4,746 | $14k | 1.6% | Plan not stated | SEC |